絞り込み

17057

広告

「"Toffoli M "[Author]」の検索結果

16件中 1件~16件表示    検索結果をPubMedで見る PubMedで見る

SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorder.

Biofluid Biomarkers in Parkinson's Disease: Clarity Amid Controversy.

Genetic causes of PD: A pathway to disease modification.

Fine-mapping of SNCA in REM sleep behavior disorder and overt synucleinopathies.

The biochemical basis of interactions between Glucocerebrosidase and alpha-synuclein in GBA1 mutation carriers.

Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial.

Evolution of prodromal parkinsonian features in a cohort of mutation-positive individuals: a 6-year longitudinal study.

Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION.

SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.

ROTEM®-guided coagulation factor concentrate therapy in trauma: 2-year experience in Venice, Italy.

[Community onset of methicillin resistant Staphylococcus aureus infections in previously healthy or health care-associated children in Argentina]

[Community-acquired methicillin-resistant Staphylococcus aureus infections in children: multicenter trial].

[Intravenous reserpine in the differential diagnosis of arterial hypertension].

[Our experience with Diamox (acetazolamide) as a test of renal function].

Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man.

Plasma levels and urinary excretion of verapamil, norverapamil, N-dealkylverapamil (D617), N-dealkylnorverapamil (D620) following oral administration of a slow-release preparation.

Sort by
※並べ替えは表示に時間がかかります